A new report finds half of adults in the United States could be eligible for popular weight loss drugs. KYW medical editor Dr ...

IST, the barometer index, the S&P BSE Sensex, shed 45.42 points or 0.07% to 76,474.96. The Nifty 50 index fell 20.60 points or 0.09% to 23,184.75.

Sociodemographic, health care, and clinical factors are associated with receipt of semaglutide in those with obesity but ...

The House of Representatives passed a bill on Thursday to mandate doctors perform lifesaving care for babies born alive after abortion attempts. The search for two teens missing on Oahu's North Shore ...

A viral video from a northeast Indianapolis gas station shows a man pointing a handgun in a woman's face and shoving her up against a car while threatening her. Police have since arrested the man on ...

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon ...

Semaglutide is a powerful aid for managing weight and Type 2 diabetes, but it’s not a free pass to stick with old habits—or skip taking action altogether. If you’ve been struggling with weight loss, ...

The American College of Cardiology announced the late-breaking science lineup for its Scientific Session to be held March ...

A Medscape survey found that a strong majority of physicians believe high-risk patients should have easier access to new weight loss drugs.

Dr. George Carroll runs BeSlimMD, a private weight loss clinic in Maitland. He has been helping patients lose weight for more than 40 years, but says when so called GLP-1 drugs made from semaglutide ...

A major new study has revealed a long list of benefits and some little-known risks of Ozempic and other GLP-1 medications.

THESE MEDICATIONS ARE MOSTLY KNOWN FOR TREATING DIABETES AND OBESITY.. BUT THE F-D-A HAS APPROVED THEM FOR PREVENTING HEART DISEASE AFTER STUDIES LAST FALL. THAT SHOWED ABOUT A 20% REDUCTION IN ...